<DOC>
	<DOCNO>NCT00413751</DOCNO>
	<brief_summary>The objective study evaluate effect brimonidine tartrate ophthalmic solution 0.15 % ( Alphagan P ) pupil diameter different luminance condition .</brief_summary>
	<brief_title>Effect Brimonidine Tartrate Ophthalmic Solution 0.15 % Pupil Diameter Normal Eyes</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Adult active duty personnel 18 50 year age best correct visual acuity 20/20 better . Patients meet state age criterion Females pregnant lactate ( non pregnant female childbearing potential pregnancy test prior participate study ) History serious ocular , neurological , cardiovascular disease History severe systemic disease History arrhythmias high blood pressure Patients currently take type ocular systemic medication except multivitamin . Patients abnormal pupil shape , Addie 's pupil , anisocoria , abnormal pupil defect .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>Large pupil render night vision difficulty halo , glare , monocular diplopia</keyword>
</DOC>